NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,035,189 | +9.0% | 53,860 | +44.2% | 0.00% | +33.3% |
| Q2 2023 | $949,310 | +225.0% | 37,345 | +362.2% | 0.00% | +200.0% |
| Q1 2023 | $292,056 | +4.7% | 8,079 | +14.7% | 0.00% | 0.0% |
| Q4 2022 | $278,982 | -80.7% | 7,045 | -77.2% | 0.00% | -85.7% |
| Q3 2022 | $1,442,000 | -18.3% | 30,948 | -23.2% | 0.01% | -12.5% |
| Q2 2022 | $1,766,000 | -52.1% | 40,293 | -21.0% | 0.01% | -38.5% |
| Q1 2022 | $3,688,000 | -7.1% | 50,995 | +4.1% | 0.01% | +8.3% |
| Q4 2021 | $3,970,000 | -26.9% | 48,975 | +5.0% | 0.01% | -33.3% |
| Q3 2021 | $5,428,000 | -31.0% | 46,642 | -1.7% | 0.02% | -33.3% |
| Q2 2021 | $7,866,000 | +22.4% | 47,448 | +3.0% | 0.03% | +12.5% |
| Q1 2021 | $6,427,000 | -16.3% | 46,074 | +3.9% | 0.02% | -14.3% |
| Q4 2020 | $7,678,000 | +26.6% | 44,358 | +1.9% | 0.03% | +7.7% |
| Q3 2020 | $6,064,000 | +21.1% | 43,531 | +3.9% | 0.03% | +8.3% |
| Q2 2020 | $5,006,000 | +24.1% | 41,902 | +3.9% | 0.02% | -4.0% |
| Q1 2020 | $4,033,000 | -14.6% | 40,340 | +0.3% | 0.02% | +4.2% |
| Q4 2019 | $4,725,000 | +21.1% | 40,202 | -11.4% | 0.02% | +9.1% |
| Q3 2019 | $3,901,000 | -20.1% | 45,373 | -39.8% | 0.02% | -21.4% |
| Q2 2019 | $4,885,000 | +6.0% | 75,345 | +2.2% | 0.03% | 0.0% |
| Q1 2019 | $4,608,000 | +32.1% | 73,719 | -17.8% | 0.03% | +12.0% |
| Q4 2018 | $3,487,000 | -59.8% | 89,676 | -41.0% | 0.02% | -52.8% |
| Q3 2018 | $8,664,000 | -35.9% | 151,994 | -10.3% | 0.05% | -42.4% |
| Q2 2018 | $13,523,000 | -31.6% | 169,359 | -25.8% | 0.09% | -34.3% |
| Q1 2018 | $19,774,000 | -3.2% | 228,152 | -22.9% | 0.14% | +0.7% |
| Q4 2017 | $20,438,000 | -21.4% | 296,027 | +3.4% | 0.14% | -28.7% |
| Q3 2017 | $26,015,000 | +30.2% | 286,259 | +6.7% | 0.20% | +30.0% |
| Q2 2017 | $19,975,000 | -3.9% | 268,373 | +23.9% | 0.15% | -10.7% |
| Q1 2017 | $20,787,000 | +43.2% | 216,617 | +8.4% | 0.17% | +29.2% |
| Q4 2016 | $14,521,000 | -47.9% | 199,847 | -25.1% | 0.13% | -47.2% |
| Q3 2016 | $27,858,000 | – | 266,867 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |